Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03406312
Other study ID # B670201731703
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2017
Est. completion date May 5, 2020

Study information

Verified date November 2021
Source University Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Roux-en-Y gastric bypass (RYGB) leads to weight reduction but has also some unwanted side effects. A part of this population will develop postprandial reactive hypoglycemia (PPRH). At this moment no validated diagnostic tool exists for PPRH. The aim of this study is to prove an association between the Sigstad´s Score and the lowest postprandial glucose level in patients after RYGB surgery. This is investigated using a liquid mixed meal tolerance test (LMMTT). As a secondary hypothesis, associations between Edinburgh Hypoglycemia Scale (EHS) and postprandial glucose levels are investigated. Furthermore, changes of insulin and GLP-1 levels during the test are analysed. Patient characteristics including co-morbidities are studied as possible influencing parameters. Moreover, a healthy control group is included to validate the results. Finally, a flowchart/diagnostic method will be proposed for diagnosing patients who had a RYBG surgery with symptoms suggestive of PPRH. Besides the LMMTT, participants at the Ghent University Hospital will undergo additional tests such as a solid mixed meal tolerance test (SMMTT) and continuous glucose monitoring (CGM). Associations between Sigstad Score, EHS and the lowest glucose measured during CGM and SMMTT will be investigated and compared to the results of the LMMTT.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 5, 2020
Est. primary completion date May 5, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - for GBS group: primary GBS, 1-5 years post surgery - for control group: 10 subjects BMI 18-25kg/m² and 10 subjects BMI >30 kg/m² Exclusion Criteria: - Antidiabetic medication (oral or injectable), somatostatin analogs - Use of systemic corticosteroids - for GBS group: Any surgery after RYGB affecting anatomic integrity of the bypass, e.g. banding, conversion of the proximal and/or distal anastomosis - for GBS group: Any surgery before RYGB affecting anatomic integrity of the bypass, e.g. banding, conversion of the proximal and/or distal anastomosis, sleeve gastrectomy - Known renal insufficiency: CDK = 4 - Known liver cirrhosis - Known cardiovascular risk: NYHA = III - Mental incapacity - Language barriers with inability to communicate with research staff - Anemia Hb < 6.2 mmol/l (10.0 g/dl) - Cancer within < 5 years - Pregnancy - Allergy to the Fresubin E - Allergy to components of the solid mixed meal (white bread, cheese spread, margarine, orange)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Post Prandial Hypoglycemia test
three test assessing hypoglycemia will be used: liquid mixed meal tolerance test, solid mixed meal tolerances test, continuous glucose monitoring

Locations

Country Name City State
Belgium Endocrinology, UZ Ghent Hospital Ghent

Sponsors (1)

Lead Sponsor Collaborator
University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Association between Sigstad's score and the lowest postprandial glucose levels we are investigating whether there is an association between the Sigtad's score and the lowest glucose levels postprandialy end 2018
Secondary Association between Ediinburgh Hypoglycemia scale and the lowest postprandial glucose levels we are investigating whether there is an association between the Ediinburgh Hypoglycemia scale and the lowest glucose levels postprandialy end 2018
Secondary flow chart for diagnosis of postprandial reactive hypoglyceamia Proposing a flowchart/diagnostic method for the diagnosis of postprandial reactive hypoglycemic syndrome which occurs in people who underwent a gastric bypass surgery end 2018
See also
  Status Clinical Trial Phase
Completed NCT04334161 - Evaluation of the Neuro-endocrine Response to Post-prandial Hyperinsulinaemic Hypoglycaemia.